Search PubMed⌕ Search

Biomedical subjects

J Fishman

Publications and source records attributed to J Fishman.

At least 109 records · Page 6Linked to original sources
PubMed1983

Scoring system for assessing the treatment of supracondylar fractures of the humerus.

This study follows up supracondylar fractures of the humerus in 41 children. Twenty-one boys and 20 girls were observed over an average period of 4.6 yr. The ages at the time of the fracture varied between 1 and 15 yr, the highest incidence occurring between 5 and 8 yr. Twenty-four patients were treated by closed reduction and long arm cast fixation, and 17 were handled by closed reduction after overhead skeletal traction. The children who were treated with skeletal traction had comparatively more-severe fractures. Although the results have no statistical significance, a greater range of motion was regained in the elbows treated by the skeletal traction method. Following treatment, none of the patients had complications from infection or from neurovascular problems. One of the problems this study posed was in comparing our work to similar published reports. We therefore developed a new scoring system for evaluating the results achieved in treatment of this type of fracture.

Adolescent↗
PubMed1983

6. Steroid metabolism in neuroendocrine structures. Specific and nonspecific components in the oxidative metabolism of estradiol by the male rat brain in vitro.

The oxidative transformation of estradiol at the C-2 and C-4 positions in the male rat brain was studied by the transfer of 3H into water from [2-3H]- and [4-3H]-estradiol. The nonenzymatic transformation at either site was linear with substrate concentration. The addition of pyridine nucleotide cofactors had no effect on the transformation at the C-4 site. The C-2 reaction was greatly enhanced by NADPH or NADH and exhibited the greatest velocity in the microsomal formation in the presence of NADH. The C-2 reaction exhibited saturation with respect to substrate and NADH with apparent KM of 1.82 microM and 0.34 mM respectively and Vmax of 81.3-76.3 pmol/mg protein/60 min. The reaction at C-4 failed to exhibit substrate saturation up to 30 microM. These data indicate that male rat brain estrogen hydroxylase is specific for the C-2 position, is NADH dependent and thus different from the corresponding liver enzyme. The reaction at C-4 in the brain tissues fails to exhibit enzymatic characteristics and the formation of 4-hydroxyestrogens in that tissue may be artifactual.

Animals↗
PubMed1982

The effect of estrogen priming of hypogonadal women on the release of gonadotropins and prolactin in response to 2-hydroxyestradiol.

We have previously shown that the administration of a 2-hydroxyestradiol (20H-E2) infusion (250 microgram/h x 4 h) to hypogonadal women resulted in a selective increase in the levels of circulating prolactin (PRL) without changes in LH or FSH. The present study concerns the effect of estrogen priming of hypogonadal women on the release of gonadotropins and PRL in response to an identical 20H-E2 infusion. Estrogen priming consisted of a 5 day course of orally administered ethinyl estradiol at a daily dose of 300 micrograms. Significant (P less than 0.05) inhibition of LH release was observed within 1 h of the onset of the 20H-E2 infusion reaching a nadir (-25 +/- 2%) by 3.75 h. The circulating levels of FSH remained unaltered for the duration of the 8 h study. In contrast, significant (P less than 0.05) increments in the release of PRL could clearly be detected after a lag period of 1.5 h reaching a peak (+91 +/- 11%) by 4 h. These and previous findings demonstrate that the inhibitory influence of 20H-E2 on gonadotropin secretion is conditional upon prior estrogen priming while the ability of 20H-E2 to stimulate the release of PRL is not.

Aged↗
PubMed1982

Formation of covalent adducts between cortisol and 16 alpha-hydroxyestrone and protein: possible role in the pathogenesis of cortisol toxicity and systemic lupus erythematosus.

The incubation of albumin with cortisol or 16 alpha-hydroxyestrone results in the formation of covalent steroid-protein adducts. The rate of adduct formation increases in the presence of sodium cyanoborohydride (NaCNBH3), indicating that the reaction proceeds nonenzymatically through a Schiff base intermediate. Under nonreducing conditions, a stable adduct forms with cortisol and 16 alpha-hydroxyestrone but not with estrone, which lacks a hydroxyl group adjacent to the reactive carbonyl. It is hypothesized that a Heyns rearrangement involving the adjacent hydroxyl group traps the Schiff base and produces a stable ketoamine adduct. The binding of 16 alpha-hydroxyestrone and cortisol to albumin is significantly inhibited by acetylsalicylic acid, which has been shown to acetylate an epsilon-amino group of a lysine residue in albumin. High-pressure liquid chromatography analysis of an acid hydrolysate of 16 alpha-hydroxyestrone-albumin shows that a product containing 16 alpha-hydroxyestrone coelutes with a standard prepared by reacting 16 alpha-hydroxyestrone with the epsilon-amino group of lysine. We propose that the formation of covalent steroid-protein adducts is a generalized phenomenon which may contribute to the pathological effects produced by elevated levels of certain endogenous steroids.

Acetylation↗
PubMed1982

Abnormal oxidative metabolism of estradiol in women with breast cancer.

The three dominant oxidative biotransformations of estradiol were examined in 10 normal women and 33 females with breast cancer by using a recently devised radiometric method. Estradiol tracers, labeled with 3H specifically in the 17 alpha, C-2, or 16 alpha position, were used to measure both the rate and extent of 17 beta-ol oxidation (the initial metabolic step) and the subsequent 2- and 16 alpha-oxidative reactions. The mean +/- SEM values for the extent of extradiol metabolism at these three specific sites for the extent of estradiol metabolism at these three specific sites were 76.9 +/- 5.3%, 31.1 +/- 4.0%, and 9.3 +/- 0.8%, respectively in normal subjects. Corresponding data in patients with breast cancer--i.e., 73.0 +/- 4.2%, 32.7 +/- 2.7%, and 14.9 +/- 1.5%--revealed a significantly greater extent of 16 alpha-hydroxylation in the latter population. Because the 16 alpha-hydroxylated compounds (including estriol) are themselves potent estrogens, these changes may have important hyperestrogenic consequences that could have a bearing on the etiology of the disease.

Adult↗
PubMed1982

Competition by estrogens for catecholamine receptor binding in vitro.

We have examined the ability of various steroids to compete for high-affinity binding of 3H-labeled ligands to catecholamine receptors in membranes prepared from rat cerebral cortex, striatum, and anterior pituitary. Ligands employed were: [3H]WB4101, [3H]prazosin, [3H]yohimbine, and [3H]clonidine (alpha-noradrenergic); [3H]dihydroalprenolol (beta-noradrenergic); [3H]spiperone and [3H]ADTN (dopaminergic). Only the 17 beta estrogens were effective and only binding of [3H]spiperone and [3H]ADTN in striatum and [3H]WB4101 and [3H]prazosin in cerebral cortex was reduced. Thus putative dopaminergic and alpha 1-noradrenergic sites alone appear to recognize estrogens. A slight competitive effect on [3H]spiperone binding to anterior pituitary membranes was also observed. Among the 17 beta estrogens tested, the most effective in all cases was the catechol estrogen 2-hydroxyestradiol (2-OHE2). The ability of 2-OHE2 (IC50 = 20-30 micro M) to inhibit ligand binding to alpha 1 receptors was comparable to that of norepinephrine (IC50 = 10-20 micro M), whereas for dopamine receptors in striatum and pituitary 2-OHE2 was an order of magnitude less effective than dopamine (IC50 = 12 micro M) in reducing binding of 3H ligands. Estradiol-17 beta and 2-hydroxyestrone were also able to inhibit binding, but the order of steroid potency was different for alpha 1 and dopaminergic receptors. Progesterone, testosterone, and corticosterone were without effect in all cases. These results show that there is specificity of steroid interactions with catecholamine receptors in the brain, both in terms of steroid structure and receptor type. The possible relevance of these interactions to neuroendocrine function is discussed.

Animals↗
PubMed1982

2-Hydroxyestrone suppresses and 2-methoxyestrone augments the preovulatory prolactin surge in the cycling rat.

The nonuterotropic metabolite of estradiol, 2-hydroxyestrone, administered at noon of proestrus to four-day cycling rats, abolishes the preovulatory prolactin rise in a large percentage of animals tested. In animals synchronized with exogenous estradiol, 2-hydroxyestrone universally induced a long delay in the prolactin surge. The principal metabolite of 2-hydroxyestrone, 2-methoxyestrone, given at noon of proestrus, significantly augments the magnitude of the preovulatory prolactin rise possibly by inhibiting the formation of endogenous 2-hydroxyestrogens in the brain. The results obtained are consistent with the concept of a physiological function for 2-hydroxyestrogens as estrogen antagonists in the CNS.

Animals↗
PubMed1982

Biochemical mechanism of aromatization.

The aromatization of androgens to estrogens by placental aromatase involves three hydroxylations which take place in sequence. The first two occur at the C-19-methyl group while the site of the final and rate-determining hydroxylation has been identified as being at 2 beta. The product of this reaction collapses to estrogen by a rapid nonenzymatic mechanism. The absence of a direct relationship between the enzyme(s) responsible for estrogen formation and the end product results in an absence of product feedback inhibition, a consequence with potential physiological implications. The proposed mechanism of estrogen formation is supported by chemical, biochemical, and immunological evidence.

Aromatase↗
PubMed1982

Abnormal estrogen and androgen metabolism in the human with systemic lupus erythematosus.

Humans with SLE were studied with regard to their ability to metabolize estradiol and testosterone. Significant abnormalities in the patterns of metabolism of both classes of sex steroids were found. Estradiol hydroxylation at C-16 was more extensive in both males and females with SLE -- leading to more estrogenic metabolites; and testosterone oxidation was elevated in patients with SLE resulting in a decrease in total androgens. Some normal first degree relatives of patients with SLE also had abnormalities of estradiol hydroxylation.

Estradiol↗
PubMed1981

Mechanism of estrogen biosynthesis. Stereochemistry of C-1 hydrogen elimination in the aromatization of 2 beta-hydroxy-19-oxoandrostenedione.

19-Hydroxy[1 alpha-3H]androstenedione was synthesized and its specific activity was accurately determined. Upon aromatization of the above material by placental microsomal aromatase preparation, a process involving 1 beta hydrogen elimination, only 7.4% of the isotope was lost establishing the alpha orientation of the 3H at C-1 in the substrate. The 19-hydroxy[1 alpha]3H]androstenedione was used as the starting material in the synthesis of 2 beta-hydroxy-19-oxo[1 alpha-3H]androstenedione which therefore had the same specific activity and isotope orientation as its precursor. The nonenzymatic collapse of 2 beta-hydroxy-19-oxo[1 alpha-3H]androstenedione in pH 7.1 buffer to estrone was associated with the elimination of only 2.6% of the isotope indicating that this process proceeds also with stereospecific 1 beta hydrogen elimination. The stereochemistry of hydrogen loss in the nonenzymatic aromatization of the 2 beta-hydroxy-19-oxo derivative is therefore beta and identical with that of estrogen biosynthesis. This provides further evidence in support of the hypothesis that the final enzymatic hydroxylation of the aromatization sequence takes place at position 2 beta of the androgen substrate and that its product, the 2 beta-hydroxy-19-aldehyde, is the proximate precursor of estrogen with the final conversion occurring nonenzymatically.

Androstenols↗
PubMed1981

Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus.

Systemic lupus erythematosus (SLE) is one of many chronic diseases with a predilection for the human female. The reasons for the high female to male (9:1) incidence remain unknown. The total extent of hydroxylation estradiol at either C-16 to more estrogenic metabolites or at C-2 to the catechol estrogens was determined by a radiometric method in the human. Comparing 23 SLE patients to 44 normal controls, an increase in the extent of hydroxylation toward the 16 alpha-metabolites was found in SLE (SLE 15.2 +/- 4.3%, range 8.8-30%; normal 9.1 +/- 2.3%, range 5.3-14.4%; P less than 0.001). Increased 16 alpha-hydroxylation was found in both males (SLE 13.2 +/- 3.0%, normal 8.3 +/- 2.1%) and females (SLE 15.7 +/- 5%, normal 9.9 +/- 2.2%) with disease when compared to normal subjects. In addition, studies of several other chronic diseases by the same method did not indicate a similar alteration in 16 hydroxylation. No change in hydroxylation at C-2 was found in male patients, but a decrease was found in female patients. These data suggest that increased hydroxylation of estradiol at C-16 occurs in SLE. The 16 alpha-metabolites have been shown to be potent estrogens, and these data might give some insight into the pathogenesis of the disease.

Adolescent↗
PubMed1980

Suppression of prolactin secretion in normal young women by 2-hydroxyestrone.

The nonuterotropic natural estrogen 2-hydroxyestrone administered to normal young women results in a prompt and profound suppression of serum prolactin in most of the subjects. With the exception of dopamine, this is the only endogenous material known to strongly inhibit prolactin secretion, and its action suggests that the physiological regulation of prolactin by estrogens in the human is dual in nature, consisting of stimulation by estradiol and inhibition by its catechol estrogen metabolite.

Adult↗